The HOPE Biobank Resource (BMT CTN 2402 HOPE)
NCT07227155
This study is recruiting at 14 US sites in 13 states, according to its ClinicalTrials.gov record last updated .
Summary
A prospective, multicenter study that will establish a repository of biospecimens and clinical data from patients undergoing hematopoietic stem cell transplant (HCT) or gene therapy (GT) for treatment of non-malignant blood diseases.
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- Aplastic Anemias
- Hemoglobinopathies
- Bone Marrow Failure
Eligibility basics and study details
- Study type
- Observational
- Phase
- Not applicable
- Ages
- Any age
- Sex
- All
- Healthy volunteers
- Accepted
- Sponsor
- Medical College of Wisconsin
- Last updated on ClinicalTrials.gov
- August 27, 2026
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
California · 1
- City of Hope · Duarte, CA
Florida · 1
- University of Florida · Gainesville, FL
Georgia · 1
- Children's Healthcare of Atlanta · Atlanta, GA
Illinois · 1
- Lurie Children's Hospital of Chicago · Chicago, IL
Missouri · 2
- St. Louis Children's · St Louis, MO
- Washington University · St Louis, MO
New York · 1
- Memorial Sloan Kettering Cancer Center · New York, NY
North Carolina · 1
- Duke University Medical Center · Durham, NC
Oregon · 1
- Oregon Health and Science University · Portland, OR
Tennessee · 1
- Vanderbilt University Medical Center · Nashville, TN
Texas · 1
- Baylor College of Medicine · Houston, TX
Virginia · 1
- Virginia Commonwealth University · Richmond, VA
Washington · 1
- Fred Hutchinson Cancer Center · Seattle, WA
Wisconsin · 1
- Children's Hospital of Wisconsin · Milwaukee, WI
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.